Minimum Age for Linzess (Linaclotide)
Linzess is approved for children aged 6 years and older for functional constipation, and for patients aged 7 years and older for irritable bowel syndrome with constipation (IBS-C), but is contraindicated in children under 2 years of age due to risk of severe dehydration and death. 1
Age-Based Indications
Functional Constipation
- Minimum age: 6 years
- FDA-approved dose: 72 mcg once daily 1
- This approval is based on a phase 3 trial demonstrating significant improvement in spontaneous bowel movement frequency (increase of 2.22 SBMs per week vs 1.05 with placebo, p<0.0001) and stool consistency in patients aged 6-17 years 2
Irritable Bowel Syndrome with Constipation (IBS-C)
- Minimum age: 7 years (recently approved) 3
- Dose: 72 mcg once daily for pediatric patients
- Adult dose: 290 mcg once daily 1
- Evidence from dose-ranging studies showed numerical improvement in bowel movement frequency with increasing doses, with good tolerability in children aged 7-17 years 4
Chronic Idiopathic Constipation (CIC)
- Adults only (age 18 years and older)
- Dose: 145 mcg once daily (or 72 mcg based on tolerability) 1
- All major trials for CIC enrolled patients aged ≥18 years 5, 6
Critical Safety Contraindication
BOXED WARNING: Linzess is absolutely contraindicated in children under 2 years of age. 1
- Nonclinical studies in neonatal mice showed deaths from dehydration after a single clinically relevant adult dose
- Risk of severe diarrhea leading to life-threatening dehydration in this age group
- Parents must be counseled to store medication securely out of reach of young children 1
Practical Considerations
Pediatric Safety Profile (Ages 6-17)
The most common adverse event in pediatric trials was diarrhea (4% with linaclotide vs 2% with placebo), with most cases being mild 2. One serious case occurred: a 17-year-old female developed severe diarrhea with dehydration requiring hospitalization and IV fluids, which resolved without sequelae 2.
Administration for Children Unable to Swallow Capsules
For patients 6 years and older who cannot swallow capsules whole, the medication can be:
- Sprinkled on applesauce
- Mixed with water and swallowed
- Administered via nasogastric or gastrostomy tube 1
Gap in Evidence
Important caveat: Linzess is not approved for IBS-C in children under 7 years of age, even though it is approved for functional constipation starting at age 6. The distinction reflects different evidence bases for these overlapping conditions 1.